Overexpression of Ang-2 mRNA in non-small cell lung cancer: Association with angiogenesis and poor prognosis

Oncology Reports

Volumn 12, Issue 4, 2004, Pages 849-853

  Takanami, Iwao ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Angiopoietin 2; Lymph node metastasis; Non small cell lung cancers; Reverse transcription polymerase chain reaction

Indexed keywords

ANGIOPOIETIN 2; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN; RNA; THRSP PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-2; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PROGNOSIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL RATE; TRANSCRIPTION FACTORS;

EID: 16644376056     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.4.849     Document Type: Article

References (22)

1. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
2. Macchiarini P, Fontanini G, Hardin MJ, Squantini F and Angellitti GA: Relation of neovasculisation to metastasis of non-small-cell lung cancer. Lancet 340: 145-146, 1992.
3. Matsuyama K, Chiba Y, Sasaki M, Tanaka H, Muraoka R and Tanigawa N: Tumor angiogenesis as a prognostic marker in operable non-small cell cancer. Ann Thoracic Surg 115: 1405-1409, 1998. (Pubitemid 28241704)
4. Duarte IG, Bufkin BL, Pennington MF, et al: Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 65: 652-659, 1998. (Pubitemid 28158083)
5. Davis S, Aldrich TH, Jones PF, et al: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161-1169, 1996. (Pubitemid 27010100)
6. Maisonpierre PC, Suri C, Jones PF, et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60, 1997. (Pubitemid 27450643)
7. Stratmann A, Risau W and Plate KH: Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153: 1459-1466, 1998. (Pubitemid 28509902)
8. Zagzag D, Hooper A, Friedlander DR, et al: In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol 159: 391-400, 1999. (Pubitemid 29485225)
9. Etoh T, Inoue H, Tanaka S, Garnard GF, Kitano S and Mori M: Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 61: 2145-2153, 2001. (Pubitemid 32692040)
10. Sfiligoi C, Luca AD, Cascone I, et al: Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer 103: 466-474, 2003. (Pubitemid 36020220)
11. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
12. Tanaka F, Ishikawa S, Yanagihara K, et al: Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res 62: 7124-7129, 2002. (Pubitemid 35424109)
13. Takanami I, Takeuchi K and Kodaira S: Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology 57: 138-142, 1999. (Pubitemid 29385492)
14. Lauren J, Gunji Y and Alitaro K: Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Path 153: 1333-1339, 1998. (Pubitemid 28509886)
15. Mitsuhashi N, Shimizu H, Ohtsuka M, et al: Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma. Hepatology 37: 1105-1113, 2003. (Pubitemid 36538687)
16. Hata K, Udagawa J, Fujiwari R, Nakayama K, Otani H and Miyazaki K: Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer. Oncology 62: 340-348, 2002. (Pubitemid 34914103)
17. Karkkainen MJ and Alotalo K: Lymphatic endothelial regulation, lymphedema and lymph node metastasis. Semin Dev Biol 13: 9-18, 2002. (Pubitemid 35418310)
18. Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K and Harkonen PL: VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 98: 946-951, 2002. (Pubitemid 34286696)
19. Stefano JM, and Micheal SP: Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 83: 852-859, 1998.
20. Koga K, Todaka N, Morioka M, et al: Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis. Cancer Res 61: 6248-6254, 2001. (Pubitemid 32762564)
21. von Netten JP, Cann SA, Maxwell CA and Finegan BP: Lymphangitis and cancer metastasis. Br J Cancer 78: 277-278, 1998.
22. Bains MS: Surgical treatment of lung cancer. Chest 100: 826-837, 1991.